Hepatitis Treatment News and Information

What is Hepatitis? (Definition)

Hepatitis is an inflammation of the liver. The liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. According to the World Health Organization, there are 5 main hepatitis viruses, referred to as types A, B, C, D and E. These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer. Hepatitis A and E are typically caused by ingestion of contaminated food or water. Hepatitis B, C and D usually occur as a result of parenteral contact with infected body fluids.

Some people who have hepatitis have no symptoms. Others may have:

  • Loss of appetite
  • Nausea and vomiting
  • Diarrhea
  • Dark-colored urine and pale bowel movements
  • Stomach pain
  • Jaundice, yellowing of skin and eyes

Some forms of hepatitis are mild, and others can be serious. Some can lead to scarring, called cirrhosis, or to liver cancer.

See below for updated news and information regarding Hepatitis including new medical research, treatment options and advancements. 

Latest Hepatitis Treatment News and Research

Hepatitis News: Researchers Identify How Hepatitis C Virus Tricks Liver Cells to Block Immune Defenses

(UNIVERSITY OF WASHINGTON HEALTH SCIENCES/UW MEDICINE) According to a recent press release, the virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells, according to University of Washington researchers and colleagues reporting Nov. 14 in Nature Medicine ...
Read More

Early Stage Study Shows Childhood Virus May Help Fight Liver Cancer and Hepatitis C

(UNIVERSITY OF LEEDS) According to a recent press release, a virus that causes childhood coughs and colds could help in the fight against primary liver cancer, according to a study. Reovirus stimulates the body's own immune system to kill off the cancerous cells, the researchers at the University of Leeds found. In addition, Reovirus is able to kill off the hepatitis ...
Read More

Hepatitis Treatment News: New Combination Therapy Shown to Clear Hepatitis C With 4 Weeks of Treatment

(PR Newswire) According to a recent press release, two injections of RG-101, in combination with a four-week course of direct-acting antiviral (DAA) therapy, has been shown to clear hepatitis C in patients at both 12 and 24 weeks after treatment in the majority of patients, according to research presented this week at The Liver Meeting® — held by the American ...
Read More

FDA Breakthrough Therapy Designation Awarded for AbbVie’s Investigational HCV Regimen

(PR Newswire) AbbVie recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for the investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibrentasvir (ABT-530) (G/P) for the treatment of patients with chronic hepatitis C virus (HCV) who failed previous therapy with direct-acting antivirals (DAAs) in genotype 1 (GT1), including therapy with an NS5A inhibitor and/or protease ...
Read More